Showing 1 - 4 results of 4 for search 'Kabagenyi, J', query time: 0.02s
Refine Results
-
1
The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial by Wajja, A, Kizito, D, Nassanga, B, Nalwoga, A, Kabagenyi, J, Kimuda, S, Galiwango, R, Mutonyi, G, Vermaak, S, Satti, I, Verweij, J, Tukahebwa, E, Cose, S, Levin, J, Kaleebu, P, Elliott, A, McShane, H
Published 2017Journal article -
2
Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A by Wajja, A, Namutebi, M, Apule, B, Oduru, G, Kiwanuka, S, Akello, M, Nassanga, B, Kabagenyi, J, Mpiima, J, Vermaak, S, Lawrie, A, Satti, I, Verweij, J, Cose, S, Levin, J, Kaleebu, P, Tukahebwa, E, McShane, H, Elliott, A
Published 2018Journal article -
3
Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control by Wajja, A, Nassanga, B, Natukunda, A, Serubanja, J, Tumusiime, J, Akurut, H, Oduru, G, Nassuuna, J, Kabagenyi, J, Morrison, H, Scott, H, Powell Doherty, R, Marshall, JL, Cabrera Puig, I, Cose, S, Kaleebu, P, Webb, EL, Satti, I, McShane, H, Elliott, AM
Published 2024Journal article -
4
Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-labe... by Wajja, A, Nassanga, B, Natukunda, A, Serubanja, J, Tumusiime, J, Akurut, H, Oduru, G, Nassuuna, J, Kabagenyi, J, Morrison, H, Scott, H, Doherty, RP, Marshall, JL, Puig, IC, Cose, S, Kaleebu, P, Webb, EL, Satti, I, McShane, H, Elliott, AM, TB042 Study Team
Published 2023Journal article